Statistics for Akero Therapeutics (id:7570 AKRO)
Valuation metrics
Market cap
2.28B
Enterprise value
1.50B
Trailing P/E (ttm)
-11.33
Forward P/E
-7.70
PEG ratio
-7.70
Price/Sales (ttm)
Price/Book (mrq)
3.09
Enterprise Value/Revenue
Enterprise Value/EBITDA
-5.56
Overview
Shares outstanding
69.80M
Float
55.41M
Shares short
3.82M
% Held by insiders
0.05%
% Held by institutions
1.05%
Average volume (10 days)
742.77K
Average volume (90 days)
Price summary
52-Week low
15.32
52-Week high
37.00
52-Week change
50.81%
Beta
-0.26
50-Day moving average
29.84
200-Day moving average
25.34
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-23.17%
Return on equity
-35.90%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-269,265,984.00
Net income to common (ttm)
-237,222,000.00
Diluted EPS (ttm)
-3.78
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
717.25M
Total cash per share (mrq)
10.28
Total debt (mrq)
36.36M
Total Debt/Equity (mrq)
4.92
Current ratio (mrq)
1.73K%
Book value per share (mrq)
10.61
Cash flow
Cash flow statement
-211,644,000.00
Levered free cash flow (LFCF)
-134,678,496.00